AVTOZMA
Live / Registered — Registered (as of 02 Jun 2026)
What this means for you
Registered since 02 Jun 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Jun 2032: the §71 affidavit of use).
Record
- Serial number
- 79429480
- Registration number
- 8279010
- Mark type
- Design + words
- Filed
- 18 Jun 2025
- Published for opposition
- 14 Apr 2026
- Registered
- 02 Jun 2026
- Next maintenance filing
- §71 affidavit of use, due by 02 Jun 2032 (grace period to 02 Dec 2032)
- Attorney of record
- Max Vern
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; pharmaceutical preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for immunity adjustment; monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases
Owner
- CELLTRION, INC., KR
- CELLTRION, INC., KR
- CELLTRION, INC., KR
Prosecution history
- 02 Sept 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 Jun 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jun 2026 — REGISTERED-PRINCIPAL REGISTER
- 14 Apr 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Apr 2026 — PUBLISHED FOR OPPOSITION
- 08 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Jan 2026 — REFUSAL PROCESSED BY IB
- 17 Dec 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 17 Dec 2025 — REFUSAL PROCESSED BY MPU
- 07 Nov 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 06 Nov 2025 — NON-FINAL ACTION WRITTEN